Industrial Pharmacy: TDDS Components

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following is an essential characteristic of polymers used in transdermal drug delivery systems (TDDS)?

Volatile and reactive

Inexpensive and highly soluble

Biocompatible and chemically compatible (correct)

Non-biodegradable and rigid

What is the role of permeation enhancers in transdermal drug delivery systems?

To act as a primary drug component

To maintain the drug's potency over time

To increase the permeability of the stratum corneum (correct)

To reduce the drug absorption required for efficacy

Which class of permeation enhancers includes compounds such as Tween and Span?

Surfactants (correct)

Amines and amides

Alcohols and polyols

Fatty acids

What is the role of permeation enhancers in transdermal systems?

Enhancing skin permeability Signup and view all the answers

What type of polymer is characterized by flexibility and elasticity used in TDDS?

Synthetic elastomers Signup and view all the answers

What is NOT a characteristic desired in a permeation enhancer for transdermal drug delivery?

Irritating to the skin Signup and view all the answers

Which of the following is an example of anionic surfactant used as a permeation enhancer?

Sodium lauryl sulfate Signup and view all the answers

What is one of the primary functions of a pressure sensitive adhesive (PSA) in transdermal drug delivery systems?

To maintain contact with the skin Signup and view all the answers

Which of the following is considered a natural polymer often used in TDDS?

Cellulose derivatives Signup and view all the answers

What is the primary function of the pressure sensitive adhesive (PSA) in a TDDS?

To adhere the patch to the skin Signup and view all the answers

Which of the following statements about backing laminates is incorrect?

Their flexibility is not essential. Signup and view all the answers

What can result from prolonged contact between the backing layer and excipients in a transdermal system?

Leaching of additives Signup and view all the answers

What characteristic makes the drug formulation suitable for passive adhesive transdermal patches?

Optimal physicochemical and biological properties Signup and view all the answers

Which material is primarily used for release liners in transdermal systems?

Polyvinyl chloride and polyethylene Signup and view all the answers

Which of these components primarily governs the release rate of a drug from a transdermal patch?

Polymer matrix Signup and view all the answers

Which of the following is NOT a mechanism by which permeation enhancers work?

Increasing lipid organization Signup and view all the answers

What property should a good permeation enhancer NOT possess?

Pharmacological activity Signup and view all the answers

What type of surfactants includes Pluronic F127 and F68?

Non-ionic surfactants Signup and view all the answers

In what way do binary systems such as propylene glycol and oleic acid function as permeation enhancers?

By promoting lipid extraction Signup and view all the answers

Which characteristic is critical for a release liner in transdermal delivery systems?

It should allow drug permeation. Signup and view all the answers

Study Notes

Industrial Pharmacy: Components of TDDS

Transdermal drug delivery systems (TDDS) components include:
- Polymer matrix/drug reservoir: The base of the TDDS, controlling drug release.
- Drug: The active pharmaceutical ingredient.
- Permeation enhancers: Chemical compounds that increase stratum corneum permeability for better drug absorption.
- Pressure-sensitive adhesive (PSA): Maintains contact between the patch and skin.
- Backing laminates: Protective layer beneath the drug reservoir.
- Release liner: Protective layer on the patch, removed before application.
- Other excipients: Supporting components, such as solvents for drug dispersion.

Polymer Matrix

Polymers form the foundation of TDDS, controlling drug release.
Polymer matrix preparation involves dispersing the drug in liquid or solid polymer base.
Biocompatibility and chemical compatibility of the polymer with the drug and other system components are crucial, including permeation enhancers.
Polymers must provide consistent and effective drug delivery throughout the product shelf life and be safe.
Examples of Natural polymers include: cellulose derivatives, zein, gelatin, shellac, waxes, gums, natural rubber, and chitosan.
Examples of Synthetic Elastomers include: polybutadiene, hydrin rubber, polyisobutylene, silicon rubber, nitrile, acrylonitrile, neoprene, butyl rubber
Examples of Synthetic Polymers include: polyvinyl alcohol, polyvinylchloride, polyethylene, polypropylene, polyacrylate, polyamide, polyurea, polymethylmethacrylate, polyvinylpyrrolidone.

Drug

The drug in TDDS needs a correct physicochemical and biological mix for successful transdermal delivery.
Ideally, drugs suitable for passive adhesive transdermal patches.

Permeation Enhancers

Permeation enhancers are chemical compounds that improve stratum corneum permeability.
They enhance the passage of drugs through the skin's outer layer, leading to improved therapeutic levels.
Permeation enhancers primarily interact with the proteins and lipids of the stratum corneum.
They modify the structure and function of the skin barrier to increase its permeability.

Permeation Enhancers: Properties and Classes

Permeation enhancers should be pharmacologically inert, non-irritating, non-toxic, non-allergenic, odorless, tasteless, colorless, compatible with other components, inexpensive, and have good solvent properties.
Different classes of permeation enhancers include:
- Alcohols and polyols (ethanol, propylene glycol)
- Surfactants (Tween, Span, SLS)
- Fatty acids (oleic acid)
- Amines and amides (N-methyl pyrrolidone)
- Terpenes (limonene)
- Sulfoxides (dimethyl sulfoxide)

Mechanism of Permeation

Enhancers modify intercellular lipid organization and fluidity.
They extract lipids from the stratum corneum.
Facilitates displacement of bound water.
May release horny cells.
Enhance solubility of drug.
Increase the drug's ability to penetrate the stratum corneum.

Classification of Permeation Enhancers

Solvents: Examples include Chloroform, Methanol, acetone isopropanol and Dichloromethane.
Surfactants:
- Anionic: Dioctyl sulphosuccinate, Sodium lauryl sulphate.
- Nonionic: Pluronic F127, Pluronic F68.
- Bile salts: Sodium taurocholate, Sodium deoxycholate.
Binary systems: Propylene glycol, oleic acid.
Miscellaneous chemicals: Urea

Pressure Sensitive Adhesive (PSA)

PSA maintains contact between the TDDS and the skin.
It should adhere using minimal pressure, be firmly attached, and easily removable without leaving residue.
Polyacrylates, polyisobutylene, and silicon-based adhesives are common in TDDS.

Backing Laminates

The backing layer's chemical resistance is critical.
Compatibility between the backing layer and other excipients is important, and prevents leaching of additives.
The backing layer safeguards drug reservoirs from environmental exposure.
Examples of materials include vinyl, polyethylene, and polyester films.

Release Liner

A protective layer on the patch during storage, removed before application.
It acts as a part of primary packaging but not the dosage form.
The liner should be chemically inert and permeable to drugs and permeation enhancers.
Typically composed with base layer (non occlusive/occlusive) and release coating layer, like silicon or Teflon.
Examples include polyester foil and other materials.

Other Excipients

Various solvents (chloroform, methanol, acetone, isopropanol, dichloromethane) are used for preparing drug reservoirs.
A protective liner covers the patch during storage.
The protective liner is removed before application.

Transdermal Patch Designs

Various designs exist for transdermal patches, including matrix and reservoir systems.

Evaluation Methods

Physico-chemical evaluation: Interaction studies, thickness measurements, weight uniformity tests, folding, moisture content, and permeability tests.
In vitro evaluation: Release studies, skin permeation studies.
In vivo evaluation: Animal studies, human models, skin irritation tests.
Stability studies: Testing for long-term stability and efficacy.
Adhesive evaluation: Tests like peel adhesion, thumb crack, rolling ball, quick test, probe tack, and shear strength are used to assess adhesive properties.

Future Scope

TDDS applications are expanding.
Current research focuses on incorporating newer drugs into TDDS systems, for various conditions.
Potentially, TDDS could be a leading method for drug delivery.

Conclusion

TDDS is beneficial for topical drug delivery.
Drugs with first-pass metabolism or instability in the gastrointestinal tract are appropriate for this method.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

Explore the essential components of transdermal drug delivery systems (TDDS). Understand the roles of polymers, drug reservoirs, permeation enhancers, and adhesive layers in developing effective TDDS. This quiz highlights key concepts crucial for pharmaceutical studies.